Document is current
Any future updates will be listed below
-
Authors
Damiano, Carla
Tarallo, Antonietta
Strollo, Sandra
Minopoli, Nadia
Valanzano, Anna
Assunto, Antonia
Tuzzi, Maria Rosaria
Brunetti-Pierri, Nicola
Ballabio, Andrea
Sorrentino, Nicolina Cristina
Parenti, Giancarlo https://orcid.org/0000-0002-6287-5748
- License Information
-
More Information
Article History
Received: 10 March 2026
Accepted: 19 May 2026
First Online: 11 June 2026
Declarations
:
: Primary human fibroblasts were obtained from an institutional biobank of anonymized samples originally collected for diagnostic purposes. All patients or legal guardians provided written informed consent for diagnostic procedures and future research use. According to institutional regulations, additional ethical approval was not required for studies performed on fully anonymized cell lines. The study complied with the Declaration of Helsinki.
: Not applicable.
: A.B. is a co-founder and shareholder of CASMA Therapeutics Inc. and serves on the advisory boards of Avilar Therapeutics and Amplify Therapeutics. The remaining authors declare that they have no competing interests.
